15.03.470 Submitting Advertisements for Approval
(a) Any advertisement for an approved medical marijuana product, which makes any claims or statements regarding efficacy, must be submitted to the Authority at least 10 business days prior to the public dissemination of the advertisement.
(b) The submitter of the advertisement must provide the following information to the Authority in addition to the advertisement itself:
(1) A cover letter that:
(A) provides the following subject line: Medical marijuana advertisement review package for a proposed advertisement;
(B) provides a brief description of the format and expected distribution of the proposed advertisement; and
(C) provides the submitter's name, title, address, telephone number, fax number, and email address;
(2) An annotated summary of the proposed advertisement showing every claim being made in the advertisement and which references support for each claim;
(3) Verification that a person identified in an advertisement as an actual patient or health care practitioner is an actual patient or health care practitioner and not a model or actor;
(4) Verification that a spokesperson who is represented as an actual patient is indeed an actual patient;
(5) Verification that an official translation of a foreign language advertisement is
accurate;
(6) Annotated references to support disease or epidemiology information, cross- referenced to the advertisement summary; and
(7) A final copy of the advertisement, including a video where applicable, in a format acceptable to the Authority.
(c) Advertising packages that are missing any of the elements in Subsection (b) above, or that fail to follow the specific instructions for submissions, shall be considered incomplete. If the Authority receives an incomplete package, it shall so notify the submitter.
(d) No advertisement may be disseminated if the submitter of the advertisement has received information that has not been widely publicized in medical literature that the use of any approved medical marijuana product may cause fatalities or serious damage to a patient.
